Prescription

Overnight Glasses Offer Prescription Glasses Lens Replacement For Any Brand, Strength, Or Prescription Type

Retrieved on: 
Tuesday, November 29, 2022

They are now offering new lenses for old frames with their prescription glasses lens replacement service that provides replacement prescription lenses for any prescription type, strength, or brand, including prescription lenses for sunglasses.

Key Points: 
  • They are now offering new lenses for old frames with their prescription glasses lens replacement service that provides replacement prescription lenses for any prescription type, strength, or brand, including prescription lenses for sunglasses.
  • Overnight Glasses have a wide selection of premium lenses, coatings, and prescription eyewear at heavily discounted prices and that are FDA and ANSI-approved.
  • Prescription Lenses For Any Task Whether you need to block blue light, use transitions lenses, or polarized and FI-41 lenses, Overnight Glasses has them available.
  • To find out more about Overnight Glasses and to read more about their prescription glasses lens replacement services, please visit their website at https://www.overnightglasses.com/ .

AMIH Majority Owned Subsidiary, EPIQ Scripts, Obtains Additional 27 U.S. State Board of Pharmacy Licenses Expanding its Online Mail-Order Pharmacy Operations

Retrieved on: 
Tuesday, November 29, 2022

Dallas, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), (“AMIH” or the “Company”), a diversified holding company that develops, acquires, and operates technology-based health and wellness companies, is pleased to announce that its majority owned subsidiary, EPIQ Scripts, LLC (“EPIQ Scripts”), has obtained an additional 27 state board of pharmacy licenses expanding its online mail-order specialty compounding pharmacy operation. Securing and obtaining licenses and accreditations in all 50 states across the U.S. has been one of EPIQ Scripts’ primary initiatives since inception in order to attract diverse telemedicine companies seeking to reach and support customers on a national level.

Key Points: 
  • More information about the MSA can be found in more detail on the Form 8-K filed by AMIH on September 8, 2022.
  • Securing pharmacy licenses in all 50 states across the U.S. has been one of our primary goals over the last several months.
  • Today the AMIH portfolio encompasses telemedicine and other virtual health platforms, subscriber based primary care and concierge medicine plans, and an online digital mail order pharmacy.
  • If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Regions Next Step Survey Finds Many Americans Aren’t Prepared for Medical Expenses

Retrieved on: 
Tuesday, November 29, 2022

Regions Bank on Tuesday announced the results of a new medical financial hardship survey that finds people are not financially prepared to cover medical expenses or pay off medical debt, despite perhaps thinking they are prepared.

Key Points: 
  • Regions Bank on Tuesday announced the results of a new medical financial hardship survey that finds people are not financially prepared to cover medical expenses or pay off medical debt, despite perhaps thinking they are prepared.
  • View the full release here: https://www.businesswire.com/news/home/20221129005180/en/
    Regions Bank on Tuesday announced the results of a new medical financial hardship survey that finds people are not financially prepared to cover medical expenses or pay off medical debt, despite perhaps thinking they are prepared.
  • Despite this, the survey finds many people are not able to cover medical bills when they are due.
  • Regions Next Step is the financial education program from Regions Bank, offering a free collection of action-oriented tips, tools and resources.

Grant Thornton names Digs with Dignity as its new Purple Paladin

Retrieved on: 
Tuesday, November 29, 2022

Grant Thornton LLP, one of Americas largest audit, tax and advisory firms, has named Digs with Dignity to its Purple Paladin program, which helps emerging nonprofit organizations move from start-up to unstoppable.

Key Points: 
  • Grant Thornton LLP, one of Americas largest audit, tax and advisory firms, has named Digs with Dignity to its Purple Paladin program, which helps emerging nonprofit organizations move from start-up to unstoppable.
  • Grant Thornton and its professionals have donated more than $720,000 to Purple Paladin nonprofits, and more than 600 Grant Thornton professionals have volunteered their time and skills to support to the firms Purple Paladins.
  • Grant Thornton LLP (Grant Thornton) is one of Americas largest audit, tax and advisory firms and the U.S. member firm of the Grant Thornton International Ltd global network.
  • Grant Thornton refers to Grant Thornton LLP, the U.S. member firm of Grant Thornton International Ltd (GTIL).

Mednow Achieves Record Q4 2022 Financial Results with +11% Q/Q Revenue Growth and 5,700% Y/Y Revenue Growth

Retrieved on: 
Tuesday, November 29, 2022

As such, these measures may not be comparable to similar financial measures that are disclosed by other companies.

Key Points: 
  • As such, these measures may not be comparable to similar financial measures that are disclosed by other companies.
  • These measures are provided as additional information that is disclosed to provide further insight into the Company's results of operations from management's perspective.
  • These measures should not be reviewed and assessed as a substitute for financial information reported under IFRS.
  • A reconciliation of the non-IFRS measures to the IFRS measure is in the section "Selected Financial Information".

NCD examines alternatives to popular prescription drug cost-effectiveness method that can discriminate

Retrieved on: 
Monday, November 28, 2022

WASHINGTON, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Today the National Council on Disability releases a policy brief that examines alternatives to a popular prescription drug cost-effectiveness methodology that has the potential to discriminate against people with disabilities.

Key Points: 
  • WASHINGTON, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Today the National Council on Disability releases a policy brief that examines alternatives to a popular prescription drug cost-effectiveness methodology that has the potential to discriminate against people with disabilities.
  • Alternatives to QALY-Based Cost-Effectiveness Analysis for Determining the Value of Prescription Drugs and Other Health Interventions supplements NCDs 2019 report, Quality Adjusted Life Years and the Devaluation of Life with a Disability .
  • With this brief, we have explored alternatives to a methodology that often does.
  • NCD is an independent, bipartisan federal agency that advises the President, Congress and other federal agencies on disability policy.

Recession Resister Launches Health Program To Fill Protection Gap For Families

Retrieved on: 
Saturday, November 26, 2022

As the cost of medical treatment in the US continues to spiral, Recession Resister announces its latest healthcare coverage solutions for families through its partnership with LifeExec.

Key Points: 
  • The company offers members a full suite of pharmaceutical, dental, vision, telemedicine, and mental health services through its partner's flagship LifeExec Advantage Wellness membership.
  • The company augments the Advantage Wellness plans with expert planning guidance from the responsive customer service team.
  • The latest LifeExec Advantage Wellness plans offer a unique combination of no age restrictions, no restrictions on pre-existing conditions, and no limits on usage.
  • The program provides a fully transparent solution to meeting the cost of healthcare in the US today with no hidden fees.

Tianda Pharma Announces 2022/23 Interim Results

Retrieved on: 
Friday, November 25, 2022

HONG KONG, Nov 25, 2022 - (ACN Newswire) - Tianda Pharmaceuticals Limited ("Tianda Pharma" or "the Group"; stock code: 0455.HK) today announced its interim results for the six months ended 30 September 2022 ("the Period").

Key Points: 
  • HONG KONG, Nov 25, 2022 - (ACN Newswire) - Tianda Pharmaceuticals Limited ("Tianda Pharma" or "the Group"; stock code: 0455.HK) today announced its interim results for the six months ended 30 September 2022 ("the Period").
  • During the Period, the Group adopted proactive marketing strategy and improved its results notably.
  • The Group has worked hard cultivating the cardiovascular, cerebrovascular and pediatric disease realms and owns unique generic product pipelines.
  • Boasting notable efficacy and competitive price, Tuoping Valsartan capsules, the Group's core product for treating cardio-cerebrovascular disease, has been ranked the No.

2B3D Launches Web Store in Support of NFT Drop and Beta Launch

Retrieved on: 
Friday, November 25, 2022

Los Angeles, CA , Nov. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Metaverse and NFT pioneer 2B3D today announced the opening of its online store at http://2b3d.games/ to aid its never-ending mission to prevent veteran suicide. 

Key Points: 
  • The prototype beta version for 2B3Ds metaverse environment for veterans simulates a typical analog medical clinic or center.
  • Todays launch of the online store provides yet another opportunity to support the project for all audiences of 2B3Ds mission to serve veterans in new critical ways.
  • Hence, the 2B3D store boasts branded hoodies, coffee mugs, long and short-sleeved T-shirts and more emblazoned with the 2B3D logo; 5% of each sale goes directly to support veterans charities (other than the core 2B3D beta launch).
  • The 2880 Genesis Collection NFT will drop on the eleventh day of the eleventh month, in honor of military veterans on Veterans Day.

Supernus to Present at the Piper Sandler 34th Annual Healthcare Conference

Retrieved on: 
Tuesday, November 22, 2022

The conference will take place November 29 December 1, 2022 at the Lotte New York Palace in New York City.

Key Points: 
  • The conference will take place November 29 December 1, 2022 at the Lotte New York Palace in New York City.
  • Investors interested in arranging a meeting with company management should contact the Piper Sandler conference coordinator.
  • An archived replay of the webcast will be available for 60 days on the Company's website following the conference.
  • Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.